Skip to main navigation Skip to search Skip to main content

Aniridia due to a novel microdeletion affecting PAX6 regulatory enhancers: case report and review of the literature

  • Andreas Syrimis
  • , Nayia Nicolaou
  • , Angelos Alexandrou
  • , Ioannis Papaevripidou
  • , Michael Nicolaou
  • , Eleni Loukianou
  • , Violetta Christophidou-Anastasiadou
  • , Stavros Malas
  • , Carolina Sismani
  • , George A. Tanteles

Research output: Contribution to journalArticlepeer-review

Abstract

Aniridia is a rare congenital ocular malformation that follows an autosomal dominant mode of inheritance. Most patients carry pathogenic point mutations in the paired box 6 gene (PAX6), but some carry deletions involving the 11p13 region, encompassing partly or completely PAX6 or the region downstream. We identified a novel deletion, ∼ 564 kb in size located about 46.5 kb downstream of PAX6 in a family with bilateral aniridia and foveal hypoplasia using array-CGH and multiplex ligation-dependent probe amplification. We also review all of the reported deletions downstream of PAX6 in patients with aniridia and/or other congenital malformations and define the overlapping region that leads to aniridia when deleted.

Original languageEnglish
Pages (from-to)555-562
Number of pages8
JournalJournal of Genetics
Volume97
Issue number2
DOIs
Publication statusPublished - 1 Jun 2018
Externally publishedYes

Keywords

  • aniridia
  • array-CGH
  • multiplex ligation-dependent probe amplification
  • PAX6 deletion

Fingerprint

Dive into the research topics of 'Aniridia due to a novel microdeletion affecting PAX6 regulatory enhancers: case report and review of the literature'. Together they form a unique fingerprint.

Cite this